Agenda for Day One - Tuesday April 27, 2027Tuesday, 27 April 2027 - ET (Eastern Time, GMT-05:00)

Pharma has never faced this level of public and political scrutiny at once: pricing anger, tariff pressure, an upended pricing model, and an industry fighting to be believed. Compliance isn't a spectator to that fight. It's the function that determines whether the industry earns its credibility back.

• Understand why trust, not enforcement risk, is becoming the real currency the industry trades in
• Explore what it takes for a compliance function to have a seat at the table when the business is under this kind of pressure
• Gain a candid, first-hand account of leading compliance through a defining public moment — what held up, what didn't

Every policy, every audit, and every hard call made ultimately serves one person: the patient waiting for the medication to work, and to be able to trust it.

• As a two-time breast cancer patient and advocate, Heidi combines authenticity, strategic insight, humor, and emotionally compelling storytelling to create presentations that resonate deeply with healthcare professionals, advocacy leaders, corporate audiences, and patient communities. Her work as a caregiver to other cancer patients is at the heart of her mission.

A candid look at what’s keeping today’s Chief Compliance Officers up at night, and how they’re adjusting their programs in real time as the ground shifts beneath them

• Define what's in scope for compliance departments in 2027 and where the boundaries should be drawn
• Assess whether trade compliance, privacy, cybersecurity, and enterprise risk now belong under the compliance umbrella
• Navigate the tension between supporting innovation and mitigating risk when enforcement direction remains unclear

• Address on the evolving False Claims Act enforcement landscape facing pharmaceutical companies, highlighting recent trends in government investigations, settlements, and litigation, including through the operation of the DOJ-HHS FCA Working Group
• Remarks will offer actionable insights for compliance professionals navigating heightened scrutiny across the life sciences industry

A direct line to what DOJ is watching right now, from the officials setting enforcement priorities for the year ahead. Hear from DOJ:

• Current priorities regarding fraud, waste and abuse in life sciences
• Emerging risk areas, from AI governance to social media to other evolving compliance touchpoints
• Identify what's changing in compliance program guidance and how DOJ expects programs to keep pace

State enforcement has become its own compliance domain, with priorities and approaches that don't always mirror federal action

• Understand where state enforcement is most active right now across marketing, transparency, pricing, and licensure
• How state-level requirements are creating compliance obligations that federal programs don't address

Hear directly from former prosecutors on how enforcement priorities translate into actual investigations and case decisions

• Latest DOJ actions and investigations and what they signal for the industry
• Updates on healthcare fraud, FCPA and corporate enforcement priorities
• How recent DOJ guidance to prosecutors’ impact pharmaceutical companies
• Evolving landscape of False Claims Act litigation

The foundational elements every compliance program needs, and how to make them work in the real world

Understand the seven core elements of an effective compliance framework

• Analyze program design for start-ups vs. mature organizations
• Explore resourcing monitoring and auditing with limited budgets
• Operationalize compliance beyond policies and training
• Gain insgight on common early-stage mistakes and how to avoid them

Privacy isn’t a separate discipline anymore; it’s woven into nearly everything that compliance touches. Build foundational fluency every compliance professional need by uncovering:

• Privacy principles every compliance professional should understand, and how they apply across compliance activities
• Where compliance and privacy receptibilities overlap, from investigations and monitoring to third-party oversight and AI-enabled tools
• Practical steps to build stronger collaboration between compliance, privacy, legal, and IT teams

Work through real AI governance dilemmas in small groups. Facilitators will guide discussions, capture insights, and help you benchmark approaches against what other compliance teams are doing right now. Participants gain skills on:

• Evaluating and approving AI use cases
• Defining ownership across compliance, legal, privacy, and IT
• Managing risk while enabling responsible AI adoption
• Building governance frameworks that can evolve with emerging technologies
• Using AI to facilitate governance and controls over licenses and credentials

The job keeps expanding. The pressure keeps building. Join experienced compliance leaders as they share what's helped them stay effective without burning out

• Discover what separates compliance leaders who burn out from those who build long, durable careers
• Discuss practical habits for staying sharp and effective over the long run
• Learn from peers who’ve navigated the hardest stretches of the job